Clinical Trials on Lung Fibrosis in New Zealand

Total 7011 results

Jiangsu Rec-Biotechnology Co., Ltd.
Iqvia Pty Ltd

Completed

Safety, Reactogenicity and Immunogenicity Study of ReCOV

Covid19

New Zealand
University of Alabama at Birmingham
University of Michigan; Tulane University; Temple University

Recruiting

GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis (GKT137831)

Idiopathic Pulmonary Fibrosis

United States
Duke University
Boehringer Ingelheim

Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry (IPF/ILD-PRO)

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

United States, Puerto Rico
GlaxoSmithKline

Completed

Study to Assess GW642444 in Asthma Patients

Pulmonary Disease, Chronic Obstructive

Australia, New Zealand
United Therapeutics

Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Interstitial Lung Disease | Progressive Pulmonary Fibrosis

United States, Canada
AbbVie
VIVUS LLC; Cystic Fibrosis Foundation; Digestive Care, Inc.; Nestlé Health Science

Terminated

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Fibrosing Colonopathy

United States
Pulmonary Fibrosis Foundation
University of Michigan

Completed

Pulmonary Fibrosis Foundation Patient Registry (PFFR)

Interstitial Lung Disease (ILD) | Idiopathic Pulmonary Fibrosis (IPF)

United States
Dicerna Pharmaceuticals, Inc.

Withdrawn

An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)

Alpha 1-Antitrypsin Deficiency

New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-AAT in Normal Adult Volunteers

Alpha 1-Antitrypsin Deficiency

New Zealand
Vaxart

Completed

Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults

Seasonal Influenza B

New Zealand
GlaxoSmithKline

Completed

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Asthma

Australia, New Zealand
Duke University
National Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute

Terminated

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)

Idiopathic Pulmonary Fibrosis

United States
Veniti

Withdrawn

VERITAS: An Evaluation of the Veniti Vidi Retrievable Inferior Vena Cava Filter System in Patients at Risk for Pulmonary Embolism (VERITAS)

Deep Vein Thrombosis | Pulmonary Embolus

New Zealand, Australia
University of Sydney
Monash University; University of Tasmania; Lung Foundation Australia

Not yet recruiting

REBUILD-SM Study for People With Interstitial Lung Disease (ILD)

Pulmonary Fibrosis | Lung Diseases, Interstitial

Australia
Boehringer Ingelheim

Active, not recruiting

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

Idiopathic Pulmonary Fibrosis

Taiwan
Fisher and Paykel Healthcare

Completed

Novel Auto-continuous Positive Airway Pressure (CPAP) Validation

Sleep Apnea, Obstructive

New Zealand
Cumberland Pharmaceuticals

Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States
Auckland City Hospital
Health Research Council, New Zealand; Australian and New Zealand College of...

Completed

Depth of Anaesthesia and Long-term Survival: The Balanced Anaesthesia Follow-up Study (BALANCEDLT)

Surgery--Complications | Long Term Adverse Effects | Post-Operative Confusion | Cognitive Dysfunction, Postoperative

New Zealand
Fisher and Paykel Healthcare

Completed

Investigative Headgear With CPAP Mask

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Investigative Headgear With Nasal Pillows Continuous Positive Airway Pressure (CPAP) Mask

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

CPAP In-home Assessment NZ

Obstructive Sleep Apnea

New Zealand
Fisher and Paykel Healthcare

Completed

Comparison of Breathing Events Detected by the SleepStyle 200 Auto Continuous Positive Airway Pressure (CPAP) Device to Attended Polysomnography

Sleep Apnea, Obstructive

New Zealand
Hoffmann-La Roche

Completed

A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (ISLAND2)

Idiopathic Pulmonary Fibrosis

United States, Germany
GlaxoSmithKline

Completed

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Asthma

United Kingdom, New Zealand
Pliant Therapeutics, Inc.

Recruiting

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Australia, Taiwan, Korea, Republic of, Portugal, Germany, United Kingdom, Argentina, Israel, Denmark, New Zealand, Netherlands, Canada, Chile, Czechia, France, Greece, Italy, Poland
Crux Biomedical

Completed

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4 (RETRIEVE 4)

Pulmonary Embolism

New Zealand, Australia
Fisher and Paykel Healthcare

Completed

An Investigation to Test a Prototype Nasal Mask in the Home Setting

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Bristol-Myers Squibb

Completed

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Mexico, Australia, Colombia, Chile, Peru
Novartis Pharmaceuticals

Completed

SD, IL-13 Production Rate in IPF

Idiopathic Pulmonary Fibrosis

United States
Fisher and Paykel Healthcare

Completed

CPAP Device In-lab Assessment NZ

Obstructive Sleep Apnea

New Zealand
Biogen

Completed

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF)

United States
AstraZeneca

Completed

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Asthma

New Zealand, United Kingdom
Fisher and Paykel Healthcare

Terminated

Physiological Study to Compare Noninvasive Ventilation (NIV) Masks

Sleep-disordered Breathing | Hypercapnia

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

New Zealand
AbbVie

Terminated

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis

Cystic Fibrosis (CF)

United States, Australia, Belgium, Hungary, Netherlands, New Zealand, Slovakia, United Kingdom
United Therapeutics

Recruiting

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease

Taiwan, Belgium, Spain, Korea, Republic of, Germany, Australia, Chile, Denmark, France, Mexico, Israel, Italy, Netherlands, Argentina, New Zealand, Peru
Fisher and Paykel Healthcare

Completed

Validation of HC250 and HC240 Series.

Obstructive Sleep Apnea (OSA)

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Mask Seal/Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Fisher and Paykel Healthcare

Completed

Evaluation of Treatment Efficacy and Comfort of a Modified Positive Airway Pressure Device to Treat Obstructive Sleep Apnea.

Obstructive Sleep Apnea (OSA)

New Zealand
Toray Industries, Inc

Completed

Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States
Fisher and Paykel Healthcare

Completed

The Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea (OSA): Comfort & Performance Trial

Obstructive Sleep Apnea | Sleep Disordered Breathing

New Zealand
Boehringer Ingelheim

Completed

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States, Canada, Turkey
Chang Gung Memorial Hospital

Recruiting

The Evaluation of Manual Therapy for the Prevention of Radiation-Induced Fibrosis in Patients With Head and Neck Cancer

Radiation-Induced Fibrosis in Patients With Head and Neck Cancer

Taiwan
Dartmouth-Hitchcock Medical Center
MaineHealth

Completed

Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment

Cystic Fibrosis

United States
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI); University of Michigan; University... and other collaborators

Active, not recruiting

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial (PRECISIONS)

Idiopathic Pulmonary Fibrosis

United States
Agenus Inc.

Terminated

Study of AGEN1884 With Pembrolizumab in 1L NSCLC

NSCLC Stage IV

New Zealand, Australia
Fisher and Paykel Healthcare

Terminated

Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing

Sleep Apnea, Obstructive | Obesity Hypoventilation Syndrome

New Zealand
John Hale

Recruiting

Antiviral Activity of Oral Probiotics

Lower Respiratory Tract Infection | Upper Respiratory Tract Infection

New Zealand

Clinical Trials on Lung Fibrosis in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations